---
title: "SRPT SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Sarepta Therapeutics (SRPT), with links to the SEC filings."
url: "https://tradytics.com/research/SRPT/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=SRPT&v=stock-11994868"
---

# SRPT financial statements and SEC filings

## SRPT annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $2.20B | -$699.78M | -$713.41M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm) |
| 2024-12-31 | $1.90B | $218.08M | $235.24M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm) |
| 2023-12-31 | $1.24B | -$267.82M | -$535.98M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm) |
| 2022-12-31 | $933.01M | -$536.20M | -$703.49M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017025029973/0000950170-25-029973-index.htm) |
| 2021-12-31 | $701.89M | -$459.71M | -$418.78M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017024022036/0000950170-24-022036-index.htm) |
| 2020-12-31 | $540.10M | -$564.16M | -$554.13M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017023005062/0000950170-23-005062-index.htm) |

## SRPT annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $3.35B | $2.21B | $1.14B | [10-Q](https://www.sec.gov/Archives/edgar/data/873303/000119312526449721/0001193125-26-449721-index.htm) |
| 2024-12-31 | $3.96B | $2.44B | $1.53B | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm) |
| 2023-12-31 | $3.26B | $2.41B | $859.34M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017025029973/0000950170-25-029973-index.htm) |
| 2022-12-31 | $3.13B | $2.74B | $384.95M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017024022036/0000950170-24-022036-index.htm) |
| 2021-12-31 | $3.15B | $2.22B | $928.01M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017023005062/0000950170-23-005062-index.htm) |
| 2020-12-31 | $2.98B | $2.22B | $761.76M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017022002517/0000950170-22-002517-index.htm) |

## SRPT annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$205.48M | -$101.97M | -$168.34M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm) |
| 2024-12-31 | -$205.79M | -$136.96M | $124.81M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm) |
| 2023-12-31 | -$500.99M | -$76.11M | $125.00M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm) |
| 2022-12-31 | -$325.35M | -$30.82M | $232.51M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017025029973/0000950170-25-029973-index.htm) |
| 2021-12-31 | -$443.17M | -$38.49M | $561.57M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017024022036/0000950170-24-022036-index.htm) |
| 2020-12-31 | $107.47M | -$82.20M | $682.32M | [10-K](https://www.sec.gov/Archives/edgar/data/873303/000095017023005062/0000950170-23-005062-index.htm) |

- [SRPT stock research](https://tradytics.com/research/SRPT)
- [SRPT financial summary](https://tradytics.com/research/SRPT/financials)
- [Read the data without JavaScript](https://tradytics.com/research/SRPT/fundamentals?snapshot=1)
